Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2022 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen. Welcome to the Atea Pharmaceuticals' Fourth Quarter and Full Year 2022 Financial Results and Business Update Conference Call.

Related Keywords

United States ,Philippines ,Japan ,Thailand ,India ,Jean Pierre Sommadossi ,John Vavricka ,Arantxa Horga ,Janet Hammond ,Tim Lugo ,Matthew Harrison ,Andrea Corcoran ,Jean Sommadossi ,William Blair ,Jonae Barnes ,Roanna Ruiz ,Morgan Stanley ,Corporate Communications At Atea Pharmaceuticals ,Generation Battery Technology Companies ,Nasdaq ,Exchange Commission ,Health Photo ,Atea Pharmaceuticals Inc ,Public Health Emergency ,Most Profitable Energy Stocks ,Atea Pharmaceuticals ,Call Transcript February ,Atea Pharmaceutical Fourth Quarter ,Full Year ,Business Update Conference ,Senior Vice President ,Investor Relations ,Corporate Communications ,Atea Pharmaceutical ,Chief Executive Officer ,Chief Development Officer ,Chief Medical Officer ,Financial Officer ,Executive Vice President ,Chief Commercial Officer ,Opportunistic Infections ,Health Emergency ,Profitable Energy ,